Treatment of disseminated ovarian cancer using nonviral interleukin‐12 gene therapy delivered intraperitoneally

By J. Fewell, M. Matar, Jennifer S. Rice, Elaine Brunhoeber, G. Slobodkin, C. Pence, Miranda Worker, D. Lewis, Khursheed Anwer. 2009

51 citations recorded by the source corpus.

Subfields: Genetics, Immunology, Reproductive Medicine

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Immunology

1. M. Jakóbisiak
2. Witold Lasek
3. R. Zagożdżon

Citations in the corpus

• Interleukin 12: still a promising candidate for tumor immunotherapy? (2014, background): “The IL-12 gene has been introduced in various viral [88–90] and non-viral [91–93] vectors, directly into growing tumors [92, 94–96] or in IL-12-engineered fibroblasts injected at the site of an established tumor [97].”